医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
(6-氨基吡啶-2-基)(1-甲基哌啶-4-基)甲酮.双盐酸盐 | (6-Aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone dihydrochloride | 613678-10-7 | C12H19Cl2N3O |
|
(6-氨基吡啶-2-基)(1-甲基哌啶-4-基)甲酮 | 2-amino-(6-(1-methylpiperidin-4-yl)carbonyl)pyridine | 613678-03-8 | C12H17N3O |
|
(6-氨基-5-溴吡啶-3-基)甲醇 | (6-amino-5-bromopyridin-3-yl)methanol | 1027785-19-8 | C6H7BrN2O |
|
(6-Tert-丁氧基羰基氨基-吡啶-2-基)-乙酸 | 6-tert-butoxycarbonylamino-2-pyridylacetic acid | 408367-22-6 | C12H16N2O4 |
|
(6-(1H-吡唑-1-基)吡啶-3-基)甲醇 | (6-(1H-pyrazol-1-yl)pyridin-3-yl)methanol | 748796-38-5 | C9H9N3O |
|
(5Z,11alpha,13E,15S)-11,15-二羟基-9-氧代(3,3,4,4-2H4)前列腺-5,13-二烯-1-酸 | PGE2-d4 | 34210-10-1 | C20H32O5 |
|
(5Z,11A,13E,15S,17Z)-11,15-二羟基-9-氧代-前列腺-5,13,17-三烯-1-酸 | Prostaglandin E3 | 802-31-3 | C20H30O5 |
|
(5Z)-5-[(4-氟-2-羟基苯基)亚甲基]-2-(四氢-1-(2H)-哒嗪基)-4(5H)-噻唑酮 | (5Z)-2-(1,2-diazinan-1-yl)-5-[(4-fluoro-2-hydroxyphenyl)methylidene]-4,5-dihydro-1,3-thiazol-4-one | 1181081-71-9 | C14H14FN3O2S |
|
(5S,8S,11S,12R)-11-((S)-仲丁基)-1-(9H-芴-9-基)-5,8- | N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(3R,4S,5S)-1-tert-butoxy-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | 474645-25-5 | C40H59N3O7 |
|
(5S,6S,9R)-6-(2,3-二氟苯基)-9-((三异丙基硅)氧基)-6,7,8,9-四氢-5H-环庚[B]吡啶-5-胺盐酸盐 | (5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-amine dihydrochloride | 1373116-04-1 | C25H38Cl2F2N2OSi |
|
(5S)-7-[4-(4-氟苯基)-6-异丙基-2-(N-甲基-N-甲磺酰基)嘧啶-5-yl]-5-羟基-3-氧代-6(E)-庚烯酸乙酯 | (S,E)-ethyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-5-hydroxy-3-oxohept-6-enoate | 901765-36-4 | C24H30FN3O6S |
|
(5S)-5-甲基-2,2-二氧代-1,2λ⁶,3-氧代噻唑烷-3-羧酸叔丁酯 | tert-butyl (S)-5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide | 396074-50-3 | C8H15NO5S |
|
(5S)-5-(羟甲基)-1,3-恶唑烷-2-酮 | (S)-5-(hydroxymethyl)-1,3-oxazolidin-2-one | 7517-99-9 | C4H7NO3 |
|
(5S)-4,5-O-(1-甲基亚乙基)-1-C-4-吗啉基-D-戊二醛-5,2-呋喃木糖 | ((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone | 1103738-19-7 | C12H19NO6 |
|
(5S)-()-2,2,3-三甲基-5-苄基-4-咪唑啉酮 | (5S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one | 132278-63-8 | C13H18N2O |
|
(5R-CIS)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯 | ((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate | 149809-43-8 | C21H21F2N3O4S |
|
(5R,8R,9R,10S,13S,14S)-13-甲基十四氢-3H-环戊二烯并[A]菲-3,17(2H)-二酮 | 5β-estrane-3,17-dione | 5696-51-5 | C18H26O2 |
|
(5R,6S)-5,6-二苯基吗啉-2-酮 | (5R,6S)-5,6-diphenylmorpholin-2-one | 282735-66-4 | C16H15NO2 |
|
(5R)-5-(2,2-二甲基-4H-1,3-苯并二氧杂环己-6-基)-1,3-恶唑烷-2-酮 | (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one | 452339-73-0 | C13H15NO4 |
|
(5R)-3-(4-溴-3-氟苯基)-5-羟甲基恶唑烷-2-酮 | (R)-3-(4-bromo-3-fluorophenyl)-5-(hydroxylmethyl)oxazolidin-2-one | 444335-16-4 | C10H9BrFNO3 |
|
(5CI)-3,5-二氨基喹啉 | quinoline-3,5-diyldiamine | 874498-26-7 | C9H9N3 |
|
(5AS,10BR)-(-)-5A,10B-二氢-2-(五氟苯基)-4H,6H-茚[2,1-B][1,2,4]三唑[4,3-D][1,4]醇四氟硼酸恶嗪 | 2-Pentafluorophenyl-6.10b-dihydro-4H,5aH-5-oxo-3,10c-diaza-2-azoniacyclopenta[c]fluorene tetrafluoroborate | 740816-14-2 | C18H11BF9N3O |
|
(5-苯基异噁唑-3-基)甲醇 | (5-phenylisoxazol-3-yl)methanol | 1619-37-0 | C10H9NO2 |
|
(5-羧基戊基)三苯基溴化磷 | (5-carboxypentyl)triphenylphosphonium bromide | 50889-29-7 | Br*C24H26O2P |
|
(5-甲基硫-3-吡啶硫代)甲基硼酸 | (5-(Methylthio)pyridin-3-ylthio)methylboronic acid | 913835-66-2 | C7H10BNO2S2 |
|
(5-甲基嘧啶-4-基)甲胺 | (5-methylpyrimidin-4-yl)methanamine | 75985-23-8 | C6H9N3 |
|
(5-甲基嘧啶-2-基)甲胺 | (5-Methylpyrimidin-2-yl)methanamine | 930272-60-9 | C6H9N3 |
|
(5-甲基吡啶-3-基)氯甲醇 | 5-methylnicotinoyl chloride | 884494-95-5 | C7H6ClNO |
|
(5-甲基-3-氧代-2-哌嗪基)乙酸 | (5-Methyl-3-oxopiperazin-2-yl)acetic acid | 405214-35-9 | C7H12N2O3 |
|
(5-甲基-1,3,4-噻二唑-2-基)三氟硼酸钾 | Potassium trifluoro(5-methyl-1,3,4-thiadiazol-2-yl)borate | 1245906-72-2 | C3H3BF3KN2S |
|
(5-甲基-1,2,4-噁唑-3-基)甲醇 | (5-methyl-1,2,4-oxadiazol-3-yl)methanol | 25977-23-5 | C4H6N2O2 |
|
(5-溴甲基吡啶基)哌啶 | 5-bromo-2-(1-piperidinylcarbonyl)pyridine | 934000-33-6 | C11H13BrN2O |
|
(5-溴噻吩-2-基)甲胺盐酸盐 | (5-bromo-2-thienyl)methanamine hydrochloride | 1001414-56-7 | C5H6BrNS*ClH |
|
(5-溴嘧啶-2-基)苯胺 | (5-bromo-pyrimidin-2-yl)-phenyl-amine | 886365-88-4 | C10H8BrN3 |
|
(5-溴嘧啶-2-基)氨基甲酸叔丁酯 | tert-butyl (5-bromopyrimidin-2-yl)carbamate | 883231-23-0 | C9H12BrN3O2 |
|
(5-溴嘧啶-2-基)乙酸 | 2-(5-bromopyrimidin-2-yl)acetic acid | 1134327-93-7 | C6H5BrN2O2 |
|
(5-溴吡啶-3-基)氨基甲酸叔丁酯 | tert-butyl (5-bromopyridin-3-yl)carbamate | 361550-43-8 | C10H13BrN2O2 |
|
(5-溴吡啶-2-基)甲基氨基甲酸叔丁酯 | 5-bromo-2-(N-methyl-N-(t-butoxycarbonyl)amino)pyridine | 227939-01-7 | C11H15BrN2O2 |
|
(5-溴-6-甲基-2-吡啶基)甲醇 | (5-bromo-6-methylpyridin-2-yl)methanol | 137778-11-1 | C7H8BrNO |
|
(5-溴-4-嘧啶)苯基甲酮 | 4-benzoyl-5-bromopyrimidine | 225794-32-1 | C11H7BrN2O |
|
(5-溴-2-甲基苯基)(5-(4-氟苯基)-2-噻吩)甲酮 | (5-bromo-2-methylphenyl)[5-(4-fluorophenyl)thiophen-2-yl]methanone | 1132832-75-7 | C18H12BrFOS |
|
(5-溴-2-氯苯基)[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲酮 | (S)-(5-bromo-2-chlorophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone | 915095-84-0 | C17H14BrClO3 |
|
(5-溴-2-氯苯基)(4-乙氧苯基)甲酮 | (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone | 461432-22-4 | C15H12BrClO2 |
|
(5-溴-2-氯-3-吡啶)甲醇 | (5-bromo-2-chloropyridin-3-yl)methanol | 742100-75-0 | C6H5BrClNO |
|
(5-溴-2-噻吩基)乙酸 | 5-bromo-2-thienylacetic acid | 71637-38-2 | C6H5BrO2S |
|
(5-溴-2-嘧啶基)甲醇 | (5-bromopyrimidin-2-yl)methanol | 22433-12-1 | C5H5BrN2O |
|
(5-溴-1H-吲唑-3-基)甲醇 | (5-bromo-1H-indazol-3-yl)methanol | 705264-93-3 | C8H7BrN2O |
|
(5-溴-1H-吲哚-3-基)-乙酸甲酯 | methyl 2-(5-bromo-1H-indol-3-yl)acetate | 117235-22-0 | C11H10BrNO2 |
|
(5-溴-1-苯并噻吩-2-基)硼酸 | 5-bromobenzo[b]thiophene-2-boronic acid | 884010-25-7 | C8H6BBrO2S |
|
(5-溴-1-苯并呋喃-2-基)甲醇 | (5-bromobenzofuran-2-yl)methanol | 38220-77-8 | C9H7BrO2 |
|